Galapagos Announces Positive Topline Results in Phase 2 Study Using FRI Imaging Parameters While Investigating New Medication for IPF Patients. The PINTA trial was a randomized, double-blind, placebo-controlled trial investigating... View Article
Tag Archive: IPF
Idiopathic pulmonary fibrosis (IPF) is a progressive disease with unclear etiology. IPF patients decline with heterogeneous trajectories. The ability to determine an individual’s disease course is limited to pulmonary function measurement... View Article
Computed tomographic biomarkers in idiopathic pulmonary fibrosis – the future of quantitative analysisJanuary 1, 2019 12:03 pm
WU et al.
AJRCCM Issues > Vol. 199, No. 1 | Jan 01, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of GLPG1690, a novel autotaxin inhibitor, to treat idiopathic pulmonary fibrosis (FLORA) – a phase 2a randomized placebo-controlled trialMay 28, 2018 12:45 pm
Maher et al.
www.thelancet.com/respiratory Published online May 20, 2018